Find the latest episode of "The Uncertain Hour" here. Listen

Valeant Pharmaceuticals and the dark side of capitalism

Jun 10, 2016
Investors' demands for more profits left patients with the choice to pay up or die.
Howard Schiller, interim CEO of Valeant Pharmaceuticals International, and Nancy Retzlaff, chief commercial officer for Turing Pharmaceuticals, listen during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC.
BRENDAN SMIALOWSKI/AFP/Getty Images